Abstract
News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.
Original language | English |
---|---|
Article number | 17420 |
Pages (from-to) | 43596-43597 |
Number of pages | 2 |
Journal | Oncotarget |
Volume | 8 |
Issue number | 24 |
DOIs | |
Publication status | Published - 25 Apr 2017 |
Keywords
- Sphingosine kinase 2
- multiple myeloma
- MM
- chemotherapeutic agents
- bortezomib